CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys...
Phase 3
Nashville, Tennessee, United States and 55 other locations
Primary Objective:Evaluate the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH).Secondary Objectives:* E...
Phase 3
Nashville, Tennessee, United States and 29 other locations
Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial ...
Phase 3
Nashville, Tennessee, United States and 338 other locations
Researchers are looking for a better way to treat people who have chronic kidney disease (CKD), CKD is a condition in which the kidneys...
Phase 2
Nashville, Tennessee, United States and 167 other locations
tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...
Phase 2, Phase 3
Nashville, Tennessee, United States and 297 other locations
A first-in-human study of KK8123 in adults with X-linked hypophosphatemia.
Phase 1, Phase 2
Nashville, Tennessee, United States and 7 other locations
savolitinib, is effective in treating patients with MET-driven PRCC, how it compares with another medication frequently used to treat this disease...
Phase 3
Nashville, Tennessee, United States and 58 other locations
The purpose of this single-arm interventional study is to evaluate the long-term safety, efficacy, and durability of the Symplicity Spyral system in...
Nashville, Tennessee, United States and 94 other locations
The purpose of this study is to assess cognitive outcome and quality of life in stable renal transplant patients treated with twice daily tacrolimus...
Phase 4
Nashville, Tennessee, United States
or more. People can take part if they have cardiovascular or chronic kidney disease. People who have at least 2 health problems rel...
Phase 3
Nashville, Tennessee, United States and 548 other locations
Clinical trials
Research sites
Resources
Legal